This flu season, GoodRx Research is tracking fills of prescription medications that treat influenza, COVID-19, and respiratory syncytial virus (RSV).

Nearly half of pet owners give their pets prescriptions, and many say the costs are putting pressure on their budgets.

GoodRx Research finds big state-by-state gaps in hair-loss treatment. See where men are most (and least) likely to fill prescriptions.

Where you live impacts the prescriptions you take. GoodRx Research breaks down the urban-rural divide in out-of-pocket prescription spending.

Original GoodRx research, an update to their 2022 analysis, reveals that much of the population still lives in a pulmonology desert, requiring over an hour of driving to reach the nearest pulmonologist.

The so-called "savings wrangler" from GoodRx, a sponsor of "GMA," shares tips to save money and time filling prescriptions. SUBSCRIBE to GMA's YouTube page: https://bit.ly/2Zq0dU5 VISIT the GMA3 homepage: https://bit.ly/3kNlst8 FOLLOW GMA3: Facebook: https://www.facebook.com/abcgma3 X: https://x.com/abcgma3 Instagram: https://instagram.com/abcgma3

Original GoodRx research reveals women spend over 50% more than men on mental health prescriptions, with the gap widening significantly with age.

Several highly anticipated drugs may be approved in 2025. Here are upcoming medications pending FDA approval you can expect to hear more about.

Several new drugs and vaccines received FDA approval in 2025. Many more will receive approval later on too. Keep an eye out for the newest drugs and vaccines with GoodRx.

GoodRx Research finds a growing number of Americans are cutting costs, skipping doses, or making risky tradeoffs to afford their medications.

New survey and prescription data reveal a disconnect between the number of men struggling with erectile dysfunction (ED) and those actually getting help.

New data from GoodRx Research reveals the burden of insurance restrictions like prior authorization, leading many to consider skipping the process altogether.

New data from GoodRx reveals that 1 in 5 women have delayed or skipped menopause treatment due to financial concerns.

This year, GoodRx is tracking fills for some of the most popular allergy medications to see how allergy sufferers are faring.

Despite high demand, insurance coverage for GIP and GLP-1 agonists like Zepbound and Ozempic remains restrictive in 2025.

Since 2021, the number of community retail pharmacies has fallen by nearly 15%, worsening pharmacy access across the U.S.

Women in the U.S. spent $8.5 billion more than men on prescriptions in 2024.